Michael O Idowu

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. doi request reprint CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
    Michael O Idowu
    Department of Pathology, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA
    Hum Pathol 43:364-73. 2012
  2. doi request reprint Pathologic diagnostic correlation with breast imaging findings: a College of American Pathologists Q-Probes study of 48 institutions
    Michael O Idowu
    Department of Pathology, Virginia Commonwealth University Health System, Richmond, 23298, USA
    Arch Pathol Lab Med 136:53-60. 2012
  3. pmc Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure
    Maciej Kmieciak
    Department of Microbiology and Immunology, Virginia Commonwealth University Massey Cancer Center, Richmond, 23298, USA
    J Transl Med 9:35. 2011
  4. pmc Elevated TRF2 in advanced breast cancers with short telomeres
    Malissa C Diehl
    Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23298, USA
    Breast Cancer Res Treat 127:623-30. 2011
  5. doi request reprint Mislabeling of cases, specimens, blocks, and slides: a college of american pathologists study of 136 institutions
    Raouf E Nakhleh
    Department of Pathology, Mayo Clinic Florida, Jacksonville, 32224, USA
    Arch Pathol Lab Med 135:969-74. 2011
  6. doi request reprint Targeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicine
    Catherine I Dumur
    Department of Pathology, Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Cancer Cytopathol 121:61-71. 2013
  7. pmc Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type
    Min Zhao
    Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, USA
    Cancer Biol Ther 13:782-92. 2012
  8. doi request reprint Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation
    Jennifer L Berrie
    Department of Microbiology and Immunology, Virginia Commonwealth University, Massey Cancer Center, Richmond, VA 23298, USA
    Transplantation 93:949-57. 2012
  9. doi request reprint Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratories
    Raouf E Nakhleh
    Department of Pathology, Mayo Clinic Florida, Jacksonville, FL 32224, USA
    Arch Pathol Lab Med 134:728-34. 2010
  10. pmc Mutations in the BRCT binding site of BRCA1 result in hyper-recombination
    Seth M Dever
    Department of Radiation Oncology, Virginia Commonwealth University, Richmond, 23298, USA
    Aging (Albany NY) 3:515-32. 2011

Collaborators

Detail Information

Publications14

  1. doi request reprint CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
    Michael O Idowu
    Department of Pathology, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA
    Hum Pathol 43:364-73. 2012
    ....
  2. doi request reprint Pathologic diagnostic correlation with breast imaging findings: a College of American Pathologists Q-Probes study of 48 institutions
    Michael O Idowu
    Department of Pathology, Virginia Commonwealth University Health System, Richmond, 23298, USA
    Arch Pathol Lab Med 136:53-60. 2012
    ..Correlation of radiologic and pathologic findings is important for optimal management of patients with image-guided breast biopsies...
  3. pmc Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure
    Maciej Kmieciak
    Department of Microbiology and Immunology, Virginia Commonwealth University Massey Cancer Center, Richmond, 23298, USA
    J Transl Med 9:35. 2011
    ..These data suggest that patients with HER-2/neu negative breast cancer might have had HER-2/neu positive premalignant lesions in the past that progressed to HER-2/neu negative breast cancer under HER-2/neu-specific immune pressure...
  4. pmc Elevated TRF2 in advanced breast cancers with short telomeres
    Malissa C Diehl
    Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23298, USA
    Breast Cancer Res Treat 127:623-30. 2011
    ..Our findings also reinforce the concept that serially propagated cancer cells, although tumor-derived, may not model all types of authentic tumors especially those demonstrating genetic heterogeneity...
  5. doi request reprint Mislabeling of cases, specimens, blocks, and slides: a college of american pathologists study of 136 institutions
    Raouf E Nakhleh
    Department of Pathology, Mayo Clinic Florida, Jacksonville, 32224, USA
    Arch Pathol Lab Med 135:969-74. 2011
    ..Inadequate specimen labels have led to patient injury from wrong patient diagnosis, wrong side treatment, and delay in diagnosis...
  6. doi request reprint Targeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicine
    Catherine I Dumur
    Department of Pathology, Virginia Commonwealth University, Richmond, Virginia 23298, USA
    Cancer Cytopathol 121:61-71. 2013
    ..The authors also discuss the critical methodologic aspects of the molecular assays used for the selection of tyrosine kinase treatment for oncology patients...
  7. pmc Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type
    Min Zhao
    Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, USA
    Cancer Biol Ther 13:782-92. 2012
    ..Collectively, our data suggest that bMSCs may contribute to the progression of basal-like breast cancers by stimulating growth and invasion but not vasculogenesis or angiogenesis...
  8. doi request reprint Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation
    Jennifer L Berrie
    Department of Microbiology and Immunology, Virginia Commonwealth University, Massey Cancer Center, Richmond, VA 23298, USA
    Transplantation 93:949-57. 2012
    ..The purpose of this study was to characterize distinct T-cell clones that were frequently and exclusively involved in GVHD or graft-versus-tumor (GVT) effects...
  9. doi request reprint Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratories
    Raouf E Nakhleh
    Department of Pathology, Mayo Clinic Florida, Jacksonville, FL 32224, USA
    Arch Pathol Lab Med 134:728-34. 2010
    ..To ensure quality human epidermal growth receptor 2 (HER2) testing in breast cancer, the American Society of Clinical Oncology/College of American Pathologists guidelines were introduced with expected compliance by 2008...
  10. pmc Mutations in the BRCT binding site of BRCA1 result in hyper-recombination
    Seth M Dever
    Department of Radiation Oncology, Virginia Commonwealth University, Richmond, 23298, USA
    Aging (Albany NY) 3:515-32. 2011
    ..Thus, certain BRCA1 mutations that cause hyper-recombination instead of reduced DSB repair might lead to breast cancer...
  11. doi request reprint Adequacy of surgical pathology reporting of cancer: a College of American Pathologists Q-Probes study of 86 institutions
    Michael O Idowu
    Department of Pathology, Virginia Commonwealth University Health System, Richmond, VA 23298, USA
    Arch Pathol Lab Med 134:969-74. 2010
    ..Inclusion of all scientifically validated elements in surgical pathology cancer reports is needed for optimal patient care...
  12. doi request reprint Equivocal or ambiguous terminologies in pathology: focus of continuous quality improvement?
    Michael O Idowu
    Department of Pathology, Virginia Commonwealth University Health System Department of Biostatistics, Virginia Commonwealth University, Richmond, VA
    Am J Surg Pathol 37:1722-7. 2013
    ..007) and "cannot exclude" (P=0.03). Focused peer review or monitoring of pathology reports with ambiguous terminologies may reduce their use and represent a worthwhile and achievable goal...
  13. pmc Lung cancer cytology: potential pitfalls and mimics - a review
    Michael O Idowu
    Department of Pathology, Virginia Commonwealth University Medical Center, Richmond, VA 23298 0662, USA
    Int J Clin Exp Pathol 3:367-85. 2010
    ..We have attempted to separate pitfalls from common potential mimics and have suggested general rules when such pitfalls are encountered...
  14. ncbi request reprint Elevated expression of nuclear Hsp90 in invasive breast tumors
    Malissa C Diehl
    Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA
    Cancer Biol Ther 8:1952-61. 2009
    ..Taken together, our data suggest that blocking nuclear Hsp90 function in advanced breast cancers may be a more targeted approach to treating advanced breast cancers that are refractory to traditional therapy...